0001611687-17-000004.txt : 20171219 0001611687-17-000004.hdr.sgml : 20171219 20171218205953 ACCESSION NUMBER: 0001611687-17-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171219 DATE AS OF CHANGE: 20171218 EFFECTIVENESS DATE: 20171219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TearSolutions, Inc. CENTRAL INDEX KEY: 0001611687 IRS NUMBER: 811764681 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-301067 FILM NUMBER: 171262682 BUSINESS ADDRESS: STREET 1: 315 OLD IVY WAY STREET 2: SUITE 301 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22903 BUSINESS PHONE: 434-951-0444 MAIL ADDRESS: STREET 1: 315 OLD IVY WAY STREET 2: SUITE 301 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22903 FORMER COMPANY: FORMER CONFORMED NAME: TearSolutions, LLC DATE OF NAME CHANGE: 20140624 D 1 primary_doc.xml X0708 D LIVE 0001611687 TearSolutions, Inc. 315 OLD IVY WAY SUITE 301 CHARLOTTESVILLE VA VIRGINIA 22903 434-951-0444 DELAWARE TearSolutions, LLC Corporation true 2015 Tom Gadek c/o TearSolutions, Inc. 315 Old Ivy Way, Suite 301 Charlottesville VA VIRGINIA 22903 Executive Officer Director Colin Rolph c/o TearSolutions, Inc. 315 Old Ivy Way, Suite 301 Charlottesville VA VIRGINIA 22903 Executive Officer W. McIlwaine Thompson, Jr. c/o TearSolutions, Inc. 315 Old Ivy Way, Suite 301 Charlottesville VA VIRGINIA 22903 Executive Officer Alexey Vinogradov c/o TearSolutions, Inc. 315 Old Ivy Way, Suite 301 Charlottesville VA VIRGINIA 22903 Director Bruce Kupper c/o TearSolutions, Inc. 315 Old Ivy Way, Suite 301 Charlottesville VA VIRGINIA 22903 Director Mark Logan c/o TearSolutions, Inc. 315 Old Ivy Way, Suite 301 Charlottesville VA VIRGINIA 22903 Director Biotechnology Decline to Disclose 06b false 2017-12-04 false true false 0 9191000 8056619 1134381 Of the Total Amount Sold, $4,181,623 in securities were issued through the conversion of outstanding Convertible Promissory Notes of the Issuer. false 24 0 0 0 false TearSolutions, Inc. /s/ Colin Rolph Colin Rolph Chief Financial Officer 2017-12-18